What is it about?
This is a review article about efficacy and safety of interferon beta 1b in relapsing-remitting form of multiple sclerosis.
Featured Image
Why is it important?
It gives an overview of evidence about efficacy and safety of interferon beta 1b, and may serve as starting point for planning future research in the field of multiple sclerosis treatment.
Perspectives
The article gives real picture about place of interferon beta 1b in multiple sclerosis treatment.
Prof Slobodan M Jankovic
Faculty of Medical Sciences, University of Kragujevac
Read the Original
This page is a summary of: Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis, Journal of Inflammation Research, March 2010, Taylor & Francis,
DOI: 10.2147/jir.s9480.
You can read the full text:
Contributors
The following have contributed to this page
